Welcome to JDRF’s Countdown magazine online!

CEO Jeffrey Brewer

Jeffrey Brewer, JDRF President & CEO

We are happy to have you as an online Countdown subscriber as we launch this new tool to communicate JDRF’s progress toward its mission.

Thanks to this new, online format, we will be able to deliver news about progress to you more frequently – every two months – while continuing to provide Countdown For Kids (online) twice a year. We have the opportunity to use new technological tools to help tell the JDRF story as effectively as possible.

It seems fitting that the online version of Countdown launches this year, as we mark 40 years since JDRF’s founding.

As you may know, JDRF was formed in 1970 by the parents of children with type 1 diabetes. These mothers and fathers had an unrelenting passion to find a cure for their sons and daughters. As the father of a teenage son with type 1 diabetes, I understand perfectly how they felt, and I’m grateful to them for having the foresight and determination to create an organization devoted to funding diabetes research.

The organization they created has become the world’s largest charitable funder of type 1 diabetes research, and a leading advocate for type 1 funding – working to get governments around the globe to devote dollars to research. We partner widely, across both the for-profit and non-profit sectors, to speed the progress of science.

Since its founding, JDRF has been committed to advancing science toward a cure, and we have made much progress in understanding how and why type 1 diabetes develops. We have shepherded the development of highly promising areas of research – beta cell regeneration, immune therapies, and islet transplantation – that we believe will lead to a cure.

At the same time, we have recognized our responsibility to help people with type 1 diabetes live as well and as healthily as possible until we can deliver that cure. Toward that end, we have funded research to create new and better treatments for complications (like diabetic eye disease and kidney disease), as well as new and better ways to manage blood sugar (such as an artificial pancreas) and reduce the risk for complications.

Today, after 40 years of research, we believe we stand at the threshold of being able to deliver therapies that could have a life-altering impact on people with type 1 diabetes. You have our commitment that we will work as aggressively as possible to make better treatments a reality, and to deliver specific, measurable benefits that improve the lives of people with type 1 diabetes.

Meanwhile, we will remain relentless in our focus on achieving what our founding families created JDRF to achieve: a cure. I firmly believe that JDRF is the organization that will drive the delivery of a cure, and we will never stop until we get there.

I am excited by the potential for progress that lies before us. But I also know that it won’t be possible to achieve it without your support. Your partnership has enabled us to get to this uniquely promising point in the history of JDRF. On behalf of everyone at JDRF, thank you for all that you have done for the foundation – and for your continued partnership as we push toward what we all want most: healthy lives for our loved ones and, one day, a world free of diabetes.

We hope you enjoy this first issue. Please don’t hesitate to send us your thoughts at countdown@jdrf.org.